Cefaloglycin
From Wikipedia, the free encyclopedia
Cefaloglycin
|
|
Systematic (IUPAC) name | |
4-(acetyloxymethyl)-8- (2-amino-2-phenyl-acetyl) amino-7-oxo-2-thia-6-azabicyclo [4.2. 0] oct-4-ene-5-carboxylic acid | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C18H19N3O6S |
Mol. mass | 405.426 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Cefaloglycin INN (also spelled cephaloglycin) is a first generation cephalosporin antibiotic.
[edit] External links
- Tune B, Hsu C (1990). "The renal mitochondrial toxicity of beta-lactam antibiotics: in vitro effects of cephaloglycin and imipenem.". J Am Soc Nephrol 1 (5): 815–21. PMID 2133431.
- Tune B, Fravert D, Hsu C (1989). "Oxidative and mitochondrial toxic effects of cephalosporin antibiotics in the kidney. A comparative study of cephaloridine and cephaloglycin.". Biochem Pharmacol 38 (5): 795–802. doi: . PMID 2930580.
|